Oxford Biomedica plc (LON:OXB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
652.00
-7.00 (-1.06%)
Mar 5, 2026, 11:30 AM GMT

Oxford Biomedica Revenue

Oxford Biomedica had revenue of 73.22M GBP in the half year ending June 30, 2025, with 70.04% growth. This brings the company's revenue in the last twelve months to 151.21M, up 55.44% year-over-year. In the year 2024, Oxford Biomedica had annual revenue of 128.80M with 43.84% growth.

Revenue (ttm)
151.21M
Revenue Growth
+55.44%
P/S Ratio
5.27
Revenue / Employee
168.02K
Employees
900
Market Cap
796.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024128.80M39.26M43.84%
Dec 31, 202389.54M-50.45M-36.04%
Dec 31, 2022139.99M-2.81M-1.97%
Dec 31, 2021142.80M55.07M62.77%
Dec 31, 202087.73M23.67M36.95%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Genus672.00M
Oxford Nanopore Technologies223.90M
hVIVO54.47M
Bioventix13.12M
Scancell Holdings4.71M
PureTech Health4.66M
4basebio1.78M
Ondine Biomedical1.18M
Revenue Rankings